ArticleAnnals of hematology2025

Polatuzumab vedotin, rituximab, cyclophosphamide, doxorubicin, and prednisone (Pola-R-CHP) therapy in diffuse large B-cell lymphoma in patients aged 80 years or older: a real-world study.

Toshiki Yamada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.